Zijian Shi

529 total citations
26 papers, 349 citations indexed

About

Zijian Shi is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zijian Shi has authored 26 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Zijian Shi's work include Inflammasome and immune disorders (8 papers), Cell death mechanisms and regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zijian Shi is often cited by papers focused on Inflammasome and immune disorders (8 papers), Cell death mechanisms and regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zijian Shi collaborates with scholars based in China, United States and United Kingdom. Zijian Shi's co-authors include Xian‐Hui He, Dong‐Yun Ouyang, Lihui Xu, Qingbing Zha, Yaping Li, Rong Xu, Yan Liang, Bo Hu, Hongrui Zhang and Fuli Shi and has published in prestigious journals such as Frontiers in Immunology, Oncotarget and Pharmacological Research.

In The Last Decade

Zijian Shi

21 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zijian Shi China 12 231 90 50 41 36 26 349
Peifeng Ke China 11 108 0.5× 70 0.8× 56 1.1× 36 0.9× 19 0.5× 54 391
Shannon Sweeney United States 12 275 1.2× 69 0.8× 89 1.8× 24 0.6× 56 1.6× 22 517
Eva Knuplez Austria 11 166 0.7× 75 0.8× 48 1.0× 17 0.4× 18 0.5× 14 395
Shishi Li China 11 158 0.7× 84 0.9× 25 0.5× 29 0.7× 22 0.6× 36 353
Michio Hara Japan 13 107 0.5× 134 1.5× 104 2.1× 32 0.8× 35 1.0× 22 458
Shumin Qin China 11 154 0.7× 27 0.3× 76 1.5× 19 0.5× 24 0.7× 25 345
Lucy Ly United Kingdom 10 168 0.7× 71 0.8× 97 1.9× 23 0.6× 61 1.7× 13 398
Dan Tan China 11 135 0.6× 23 0.3× 30 0.6× 48 1.2× 23 0.6× 30 348
Maya Sultan Israel 8 137 0.6× 36 0.4× 78 1.6× 18 0.4× 39 1.1× 10 337
Menglu Fu China 11 127 0.5× 29 0.3× 50 1.0× 15 0.4× 19 0.5× 16 342

Countries citing papers authored by Zijian Shi

Since Specialization
Citations

This map shows the geographic impact of Zijian Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zijian Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zijian Shi more than expected).

Fields of papers citing papers by Zijian Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zijian Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zijian Shi. The network helps show where Zijian Shi may publish in the future.

Co-authorship network of co-authors of Zijian Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Zijian Shi. A scholar is included among the top collaborators of Zijian Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zijian Shi. Zijian Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yaping, X. H. Niu, Ge Zhang, et al.. (2025). Anti-alcoholism drug disulfiram inhibits PANoptosis by blocking mitochondrial permeabilization in macrophages. Frontiers in Immunology. 16. 1726408–1726408.
2.
Shi, Zijian, Baichuan Wang, Shuo Wang, et al.. (2025). Integration of Single-Cell and Bulk Transcriptomes to Identify a Poor Prognostic Tumor Subgroup to Predict the Prognosis of Patients with Early-stage Lung Adenocarcinoma. Journal of Cancer. 16(4). 1397–1412. 2 indexed citations
3.
Sun, Nan, Liu Duan, Onyee Chan, et al.. (2025). Theaflavin suppresses necroptosis by attenuating RIPK1-RIPK3-MLKL signaling and mitigates cisplatin-induced kidney injury in mice. International Immunopharmacology. 157. 114761–114761.
4.
Chen, Zhiqiang, Bo Wang, Chao Liu, et al.. (2025). Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions. Journal of Nanobiotechnology. 23(1). 514–514. 1 indexed citations
5.
Yang, Haiyan, Yaping Li, Zijian Shi, et al.. (2024). Scutellarin inhibits inflammatory PANoptosis by diminishing mitochondrial ROS generation and blocking PANoptosome formation. International Immunopharmacology. 139. 112710–112710. 25 indexed citations
6.
Liang, Yan, Yaping Li, Zijian Shi, et al.. (2024). Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages. Acta Pharmacologica Sinica. 46(2). 430–447. 33 indexed citations
7.
Liu, Xiyu, Zijian Shi, Yuan Cao, et al.. (2024). The role of PDCD6 in stemness maintenance of Glioblastoma. Pathology - Research and Practice. 264. 155727–155727. 1 indexed citations
8.
Zhao, Wenhao, Chen Ding, Meiru Zhao, et al.. (2024). Identification and Validation of a Hypoxia and Glycolysis Prognostic Signatures in Lung Adenocarcinoma. Journal of Cancer. 15(6). 1568–1582. 3 indexed citations
9.
Zhang, Hongrui, Zijian Shi, Siyuan Chen, et al.. (2023). Triptolide induces PANoptosis in macrophages and causes organ injury in mice. APOPTOSIS. 28(11-12). 1646–1665. 30 indexed citations
10.
Chen, Siyuan, Yaping Li, Hongrui Zhang, et al.. (2023). Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly. Acta Pharmacologica Sinica. 44(10). 2019–2036. 15 indexed citations
11.
Shi, Fuli, Qing Li, Yaping Li, et al.. (2023). Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis. Pharmacological Research. 189. 106697–106697. 43 indexed citations
12.
Shi, Zijian, Siyuan Chen, Yaping Li, et al.. (2023). Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice. International Immunopharmacology. 117. 109974–109974. 20 indexed citations
13.
Li, Zihao, Li Y, Hua Huang, et al.. (2022). Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network. Frontiers in Genetics. 13. 940167–940167. 6 indexed citations
14.
Huang, Hua, Zijian Shi, Li Y, et al.. (2022). Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis. Frontiers in Oncology. 12. 850943–850943. 9 indexed citations
15.
Xu, Rong, Siying Liu, Bo Hu, et al.. (2021). Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes. International Immunopharmacology. 102. 108380–108380. 11 indexed citations
16.
Shi, Zijian, Bo Zeng, Lihui Xu, et al.. (2020). Berberine augments hypertrophy of colonic patches in mice with intraperitoneal bacterial infection. International Immunopharmacology. 90. 107242–107242. 5 indexed citations
17.
Li, Chenguang, Yan Liang, Feng‐Yi Mai, et al.. (2017). Baicalin Inhibits NOD-Like Receptor Family, Pyrin Containing Domain 3 Inflammasome Activation in Murine Macrophages by Augmenting Protein Kinase A Signaling. Frontiers in Immunology. 8. 1409–1409. 40 indexed citations
18.
Pan, Hao, Lihui Xu, Qingbing Zha, et al.. (2015). Piperine metabolically regulates peritoneal resident macrophages to potentiate their functions against bacterial infection. Oncotarget. 6(32). 32468–32483. 33 indexed citations
19.
Wang, Lixian, Chenguang Li, Xiaoyu Zhang, et al.. (2015). Cucurbitacin E suppresses cytokine expression in human Jurkat T cells through down-regulating the NF-κB signaling. Acta Biochimica et Biophysica Sinica. 47(6). 459–465. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peifeng Ke Breakdown of academic impact, for papers by Shannon Sweeney Breakdown of academic impact, for papers by Eva Knuplez Breakdown of academic impact, for papers by Shishi Li Breakdown of academic impact, for papers by Michio Hara Breakdown of academic impact, for papers by Shumin Qin Breakdown of academic impact, for papers by Lucy Ly Breakdown of academic impact, for papers by Dan Tan Breakdown of academic impact, for papers by Maya Sultan Breakdown of academic impact, for papers by Menglu Fu
Rankless by CCL
2026